Camilla Loi

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Venues

Dermatologic therapy

Universita degli Studi di Bologna Azienda Ospedaliera Sant'Orsola-Malpighi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universita degli Studi di Bologna Azienda Ospedaliera Sant'Orsola-Malpighi Nov 1o 2017

Italy

PhD :: DIMES

Publications

Federica Filippi, Miriam Anna Carpanese, Lidia Sacchelli, Camilla Loi, Marco Adriano Chessa, Federico Bardazzi
Two birds with one stone: Successful treatment with methotrexate in a patient with generalized eruptive keratoacanthoma of Grzybowski and rheumatoid arthritis. Dermatologic therapy 35 (11) (2022)
Federico Bardazzi, Miriam Anna Carpanese, Diego Abbenante, Federica Filippi, Lidia Sacchelli, Camilla Loi
New-onset bullous pemphigoid and flare of pre-existing bullous pemphigoid after the third dose of the COVID-19 vaccine. Dermatologic therapy 35 (7) (2022)
Federico Bardazzi, Giuseppe Gallo, Camilla Loi, Cosimo Misciali, Annalisa Patrizi, Andrea Filippini
Refractory palmo-plantar discoid lupus erythematosus successfully treated with mycophenolate mofetil: Unusual localization and literature review. Dermatologic therapy 34 (2) (2021)
Federico Bardazzi, Camilla Loi, Adriano Chessa Marco, Ambra Di Altobrando, Federica Filippi, Rossella Lacava, Filippo Viviani, Riccardo Balestri, Miriam Leuzzi, Lidia Sacchelli
Therapeutic approaches and targets for treatment of autoimmune bullous diseases. Dermatologic therapy 34 (5) (2021)
Lidia Sacchelli, Michela Magnano, Camilla Loi, Annalisa Patrizi, Federico Bardazzi
The unforeseen during biotechnological therapy for moderate-to-severe psoriasis: How to manage pregnancy and breastfeeding, infections from Mycobacterium tuberculosis, hepatitis B virus, hepatitis C virus, and HIV, surgery, vaccinations, diagnosis of malignancy, and dose tapering. Dermatologic therapy 33 (3) (2020)
Federico Bardazzi, Cosimo Misciali, Valeria Evangelista, Camilla Loi
Ulcerative colitis and progressive acquired hyperpigmentation on the face and neck. A case of infliximab-related lichen planus pigmentosus. Dermatologic therapy 33 (6) (2020)
Federica Filippi, Camilla Loi, Valeria Evangelista, Federico Bardazzi
COVID-19 era: A chance to learn something new about monitoring psoriatic patients in biological therapy. Dermatologic therapy 33 (4) (2020)
Camilla Loi, Michela Magnano, Giulia Maria Ravaioli, Lidia Sacchelli, Annalisa Patrizi, Federico Bardazzi
Rituximab therapy in pemphigus: A long-term follow-up. Dermatologic therapy 32 (1) (2018)
Federico Bardazzi, Miriam Leuzzi, Francesca Ferrara, Annalisa Patrizi, Camilla Loi
Does chronic immunosuppressive therapy for autoimmune disease influence the risk of developing active tuberculosis? Dermatologic therapy 32 (1) (2018)

Camilla Loi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Camilla Loi